Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Anthrax Detection: Agencies Need to Validate Sampling Activities in Order to Increase Confidence in Negative Reults

GAO-05-493T Published: Apr 05, 2005. Publicly Released: Apr 05, 2005.
Jump To:
Skip to Highlights

Highlights

In September and October 2001, letters laced with Bacillus anthracis (anthrax) spores were sent through the mail to two U.S. senators and to members of the media. These letters led to the first U.S. cases of anthrax disease related to bioterrorism. In all, 22 individuals, in four states and Washington, D.C., contracted anthrax disease; 5 died. These cases prompted the Subcommittee to ask GAO to describe and assess federal agencies' activities to detect anthrax in postal facilities, assess the results of agencies' testing, and assess whether agencies' detection activities were validated.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

AnthraxBiological agentsDisease detection or diagnosisDiseasesHealth hazardsHomeland securityInfectious diseasesInteragency relationsLaboratoriesPostal facilitiesPostal serviceStrategic planningTerrorismTest facilitiesTestingBioterrorismDisease surveillance